ArticleJournal of Indian Society of Periodontology
Estimation of plasma afamin levels in patients with periodontitis and Type II diabetes mellitus: A clinico-biochemical study.
Article in Journal of Indian Society of Periodontology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Periodontitis is a chronic inflammatory disease, modified by host immune response, where the host-microbial interaction damages proteoglycan, hyaluronan, and collagen, leading to connective tissue breakdown and impaired wound healing due to increased oxidative stress (OS). Afamin (AFM) is a Vitamin E-binding protein that plays a role in antiapoptotic cellular processes related to OS and has been previously associated with the development of insulin resistance (IR). Type II diabetes mellitus (TIIDM) is a major risk factor for periodontitis. The aim of this study was to assess plasma AFM levels in subjects diagnosed with periodontitis, with and without TIIDM. Materials and Methods: Seventy-five participants were divided into 3 groups: Group I - 25 healthy controls, Group II - 25 systemically healthy individuals with periodontitis, and Group III - 25 individuals with periodontitis and TIIDM. All periodontal parameters, i.e. plaque index, gingival index, and probing pocket depth, were recorded. Glycemic control in Group III individuals was assessed by glycated hemoglobin (HbA1c) levels. Plasma AFM levels were analyzed using the enzyme-linked immunosorbent assay technique. Results: Mean plasma AFM concentrations in Group I were 30.64 ± 5.88 ng/ml. A significant increase in mean AFM was seen in Group II and III, i.e. 50.76 ± 9.65 ng/ml and 86.44 ± 12.10 ng/ml, respectively. A correlation was seen between deep pockets and increased AFM concentration in both the test groups. It was also found that mean AFM concentrations increased with worsening of glycemic control, i.e. 80.25 ng/ml, 84.25 ng/ml, and 90.92 ng/ml in good, fair, and poor HbA1c control patients, respectively. Conclusions: Plasma AFM is increased in patients with periodontitis. A higher concentration is seen in patients with periodontitis and TIIDM. OS being the reason for its increase, plasma AFM levels can be used as a marker to identify the incidence of TIIDM in individuals with periodontitis or other inflammatory conditions associated with increased OS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.